Sign Up to like & get
recommendations!
0
Published in 2021 at "Melanoma research"
DOI: 10.1097/cmr.0000000000000765
Abstract: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced melanoma. Combination of ICI with ipilimumab cytotoxic T-lymphocyte antigen-4 and nivolumab [anti-programmed cell death-1 (PD-1)] improves tumoral response compared to anti-PD1 monotherapy in melanoma patients,…
read more here.
Keywords:
combination;
aseptic cystitis;
melanoma;
cystitis ... See more keywords